MatchaDB

2022학술 논문무료 열람

Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet.

Wang Y, Yu Y, Ding L, Xu P, Zhou J

Frontiers in nutrition

출판사에서 읽기→무료 전문→PubMedPubMed Central

초록

Obesity induced by a high-fat diet (HFD) is an increasing global health problem, leading to many metabolic syndromes. As the emerging food additive rich in tea polyphenols, theanine, caffeine, and so on, matcha green tea has gained more and more popularity for its outstanding potential in ameliorating metabolic disorders. This study investigated the composition and antioxidant activity of matcha green tea and further explored its effects on gut-liver axis homeostasis in an HFD-induced obese mouse model. Male (7-8 weeks old) C57BL/6J mice were divided into four groups with the following dietary supplementation for 8 weeks: a normal chow diet (NCD), a normal chow diet+1.0% matcha (NCM), a high-fat diet (HFD), and a high-fat diet+1.0% matcha (HFM). The results demonstrated that matcha green tea ameliorated the development of obesity, lipid accumulation, and hepatic steatosis induced by HFD. Subsequently, dietary matcha supplementation restored the alterations in fecal bile acid profile and gut microbial composition. Meanwhile, the levels of mRNA expression in hepatocytes demonstrated that matcha intervention made significant regulatory on the multiple metabolic pathways of hosts involved in glucose, lipid, and bile acid metabolism. These findings present new evidence for matcha green tea as an effective nutritional strategy to mitigate obesity and relevant metabolic disorders through the gut-liver axis.

초록 텍스트는 PubMed, OpenAlex 또는 Europe PMC에서 가져온 것이며 저자와 출판사에 귀속됩니다.

연구 유형

동물 연구

쥐, 물고기 등 동물을 대상으로 한 실험.

제목, 초록, 주제어에서 자동으로 지정됩니다.

주제

여기서는 말차가 주요 주제입니다(제목에 명시).

키워드와 주제어

내 연구 폴더

이 연구 인용하기

Wang Y, Yu Y, Ding L, Xu P, Zhou J. (2022). Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet. Frontiers in nutrition. https://doi.org/10.3389/fnut.2022.931060

DOI: 10.3389/fnut.2022.931060 · PubMed ID: 35978960 · 30회 인용됨 (OpenAlex)

대사와 체중에 대해 더 보기

2018학술 논문무료 열람

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

시험관·세포 연구대사와 체중항산화 물질과 폴리페놀암75회 인용됨
2020학술 논문

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ 외 — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

동물 연구대사와 체중장과 마이크로바이옴시장·문화·지속 가능성74회 인용됨

라이브러리 전체 둘러보기→